ETH researchers working with Martin Fussenegger have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.
Alongside cardiovascular disease, cancer has become the top cause of death in industrialised countries. Many of those affected are diagnosed only after the tumour has developed extensively. This often reduces the chance of recovery significantly: the cure rate for prostate cancer is 32 percent and only 11 percent for colon cancer. The ability to detect such tumours reliably and early would not only save lives, but also reduce the need for expensive, stressful treatment.
Researchers working with Martin Fussenegger, Professor at the Department of Biosystems Science and Engineering at ETH Zurich in Basel, have now presented a possible solution for this problem: a synthetic gene network that serves as an early warning system. It recognises the four most common types of cancer – prostate, lung, colon and breast cancer – at a very early stage, namely when the level of calcium in the blood is elevated due to the developing tumour.
Derailed calcium balance triggers melanin production
The early warning system comprises a genetic network that biotechnologists integrate into human body cells, which in turn are inserted into an implant. This encapsulated gene network is then implanted under the skin where it constantly monitors the blood calcium level.
As soon as the calcium level exceeds a particular threshold value over a longer period of time, a signal cascade is triggered that initiates production of the body’s tanning pigment melanin in the genetically modified cells. The skin then forms a brown mole that is visible to the naked eye.
The mole appears long before the cancer becomes detectable through conventional diagnosis. “An implant carrier should then see a doctor for further evaluation after the mole appears,” explains Fussenegger. It is no reason to panic. “The mole does not mean that the person is likely to die soon,” stresses the ETH professor. It simply means that clarification and if necessary treatment are needed.
The researchers used calcium as the indicator of the development of the four types of cancer, as it is regulated strongly in the body. Bones serve as a buffer that can balance out concentration differences. However, when too much calcium is detected in the blood, this may serve as a sign for one of the four cancers.
Early detection increases survival rate
“Early detection increases the chance of survival significantly,” says Fussenegger. For example, if breast cancer is detected early, the chance of recovery is 98 percent; however, if the tumour is diagnosed too late, only one in four women has a good chance of recovery. “Nowadays, people generally go to the doctor only when the tumour begins to cause problems. Unfortunately, by that point it is often too late.”
The implant also has an additional advantage: “It is intended primarily for self-monitoring, making it very cost effective,” explains the ETH professor. However, for those who would prefer not to deal with the constant stress, an implant can also be used that develops a mark visible only under a red light. “This regular check could be carried out by their doctor.”
The disadvantage is that the service life of such an implant is limited, as Fussenegger has found in literature. “Encapsulated living cells last for about a year, according to other studies. After that, they must be inactivated and replaced.”
A reliable prototype
So far, this early warning implant is a prototype; the associated work recently published in the journal Science Translational Medicine is a feasibility study. The researchers have tested their early warning system in a mouse model and on pig skin. It functioned reliably during these tests. Moles developed only when the calcium concentration reached a high level.
The Basel-based scientists still have a long way to go before human testing can begin. “Continued development and clinical trials in particular are laborious and expensive, which we as a research group cannot afford,” says the ETH professor. However, he would like to promote the translation of his developments, so that one day they will lead to applicable products. He estimates that bringing such a cancer diagnosis implant to market maturity will take at least ten years of research and development.
The concept of the “biomedical tattoo”, as Fussenegger describes this new finding, would also be applicable to other gradually developing illnesses, such as neurodegenerative diseases and hormonal disorders. In principle, the researchers could replace the molecular sensor to measure biomarkers other than calcium.
Learn more: An artificial mole as an early warning sign
The Latest on: Synthetic gene network
via Google News
The Latest on: Synthetic gene network
- Researchers use gene editing to create single-sex mice litterson December 3, 2021 at 2:15 am
Scientists have used gene-editing technology to create female-only and male-only mice litters with 100% efficiency. The technology could be used to improve animal welfare in scientific research and ...
- Rules to create gene-edited farm animals must put welfare first - reviewon November 30, 2021 at 10:09 pm
Regulations to allow the production of gene-edited farm animals must put welfare first, according to an independent review. The technology allows scientists to alter DNA so as to introduce specific ...
- MeiraGTx to Provide a Xerostomia Clinical Program Update and Host a Virtual Research and Development Day on Gene Regulationon November 29, 2021 at 1:33 pm
The inducible gene expression platform is based on synthetic riboswitches rationally designed for mammalian cells, a short RNA hairpin sequence that includes a small molecule binding aptamer that ...
- OriCiro Genomics Launches New enzymatic DNA synthesis tool for commonly used vectorson November 29, 2021 at 6:23 am
OriCiro Genomics Inc., a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapeutics and synthetic biology, today announced the launch of OriCiro® Cell-Free ...
- Diabetes: Concepts of β-Cell Organ Dysfunction and Failure Would Lead to Earlier Diagnoses and Prevention.on November 26, 2021 at 11:04 pm
An essential approach to both pandemics is prevention and unrealized earlier treatment. Thus, in this Perspective relating to diabetes, we emphasize a paradigm of, first, reversible β-cell organ ...
- Global Synthetic Biology Service Market 2021 Comprehensive Research Methodology, Key Insights, Segments and Extensive Profiles by 2027on November 22, 2021 at 8:02 am
Nov 22, 2021 (CDN Newswire via Comtex) -- Global Synthetic Biology Service Market Growth (Status and Outlook) 2021-2027 supplies you with a comprehensive study of the market conducted with the ...
- Deciphering the impact of gene loss on biological evolutionon November 17, 2021 at 10:17 am
Specifically, it reveals that the massive gene losses which deconstructed the gene network in the heart of tunicates eased the transition to a free pelagic lifestyle in appendicularian tunicates ...
- How gene editing could be used as a weapon, and what to do about iton November 15, 2021 at 11:44 am
Gene editing technologies such as CRISPR are getting cheaper and easier to work with. That means rogue scientists or organizations could use them for bioterrorism.
- Multiplex Network Maps All Genes and Interactions on Multiple Levels to Help Understand Rare Disease Mechanismson November 10, 2021 at 12:00 am
For their current study, first author Pisanu Buphamalai, a CeMM PhD student in Menche’s research group, built a multilayer network mapping more than 20 million gene relationships with ...
via Bing News